Ascencio SCA
XBRU:ASCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascencio SCA
XBRU:ASCE
|
BE |
|
A
|
Atrys Health SA
MAD:ATRY
|
ES |
|
Gevo Inc
NASDAQ:GEVO
|
US |
|
A
|
Adidas AG
XBER:ADS
|
DE |
|
CareDx Inc
NASDAQ:CDNA
|
US |
|
Gujarat State Fertilizers and Chemicals Ltd
NSE:GSFC
|
IN |
|
Talen Energy Corp
NASDAQ:TLN
|
US |
|
G
|
Genesis AI Corp
CNSX:AIG
|
CA |
|
Mitsubishi UFJ Financial Group Inc
TSE:8306
|
JP |
|
CMS Energy Corp
NYSE:CMS
|
US |
|
N
|
Novabase SGPS SA
ELI:NBA
|
PT |
Wall St Price Targets
ASCE Price Targets Summary
Ascencio SCA
According to Wall Street analysts, the average 1-year price target for ASCE is 54.83 EUR with a low forecast of 51.51 EUR and a high forecast of 58.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ASCE's stock price target?
Price Target
54.83
EUR
According to Wall Street analysts, the average 1-year price target for ASCE is 54.83 EUR with a low forecast of 51.51 EUR and a high forecast of 58.8 EUR.
What is the Revenue forecast for Ascencio SCA?
Projected CAGR
3%
Over the last 4 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Ascencio SCA?
Projected CAGR
4%
Over the last 4 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Ascencio SCA?
Projected CAGR
5%
Over the last 4 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 3 years is 5%.
